Retrospective Analysis of Prevalence and Treatment Patterns of Skin and Nail Candidiasis From US Health Insurance Claims Data

Kaitlin Benedict; Shari R Lipner; Jeremy A W Gold

doi:10.12788/cutis.1335

Retrospective Analysis of Prevalence and Treatment Patterns of Skin and Nail Candidiasis From US Health Insurance Claims Data

Cutis. 2026 Feb;117(2):51-53. doi: 10.12788/cutis.1335.

Authors

Kaitlin Benedict¹, Shari R Lipner¹, Jeremy A W Gold¹

Affiliation

¹ Kaitlin Benedict and Dr. Gold are from the Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia. Dr. Lipner is from the Israel Englander Department of Dermatology, Weill Cornell Medicine, New York, New York.

PMID: 41941577
DOI: 10.12788/cutis.1335

Abstract

Candidiasis of the skin and nails is caused by overgrowth of Candida species due to excess skin moisture, skin barrier disruption, or immunosuppression. Data on the prevalence of candidiasis of the skin and nails in the United States are scarce. In this study, we evaluated the prevalence, characteristics, and treatment practices of candidiasis of the skin and nails using data from 2 large US health insurance claims databases.

MeSH terms

Adolescent
Adult
Aged
Antifungal Agents* / therapeutic use
Candidiasis, Cutaneous* / drug therapy
Candidiasis, Cutaneous* / epidemiology
Child
Child, Preschool
Databases, Factual
Female
Humans
Insurance Claim Review
Insurance, Health / statistics & numerical data
Male
Middle Aged
Onychomycosis* / drug therapy
Onychomycosis* / epidemiology
Prevalence
Retrospective Studies
United States / epidemiology
Young Adult

Substances

Antifungal Agents